Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma

BackgroundThis paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma.MethodsThe alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package....

Full description

Bibliographic Details
Main Authors: Weiwei Liang, Fangfang Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.538364/full
_version_ 1818557898955948032
author Weiwei Liang
Fangfang Sun
author_facet Weiwei Liang
Fangfang Sun
author_sort Weiwei Liang
collection DOAJ
description BackgroundThis paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma.MethodsThe alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package. Prognosis-associated AS events by using univariate Cox regression analysis were selected. Gene functional enrichment analysis demonstrated the potential pathways enriched by survival-associated AS. Prognosis-related splicing events were submitted to develop moderate predictors using Lasso regression model.ResultsOne thousand five survival-associated alternative splicing events were identified. The prognostic genes included ATXN2L, MEIS1, IKBKB, COX4I1. Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway. A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set. ROC analysis showed good performance of the prediction model in test set. Then, a nomogram integrating the clinical-pathological factors and riskscore was constructed for predicting 1‐ and 3‐year survival rate.ConclusionOur data provide a comprehensive bioinformatics analysis of AS events in ACC, providing biomarkers for disease progression and a potentially rich source of novel therapeutic targets.
first_indexed 2024-12-14T00:05:44Z
format Article
id doaj.art-c4a4e31421ea403e936a6814004d657d
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-14T00:05:44Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-c4a4e31421ea403e936a6814004d657d2022-12-21T23:26:04ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-03-011210.3389/fendo.2021.538364538364Prognostic Alternative mRNA Splicing in Adrenocortical CarcinomaWeiwei Liang0Fangfang Sun1Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaKey Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Cancer Institute, Zhejiang University School of Medicine, Hangzhou, ChinaBackgroundThis paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma.MethodsThe alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package. Prognosis-associated AS events by using univariate Cox regression analysis were selected. Gene functional enrichment analysis demonstrated the potential pathways enriched by survival-associated AS. Prognosis-related splicing events were submitted to develop moderate predictors using Lasso regression model.ResultsOne thousand five survival-associated alternative splicing events were identified. The prognostic genes included ATXN2L, MEIS1, IKBKB, COX4I1. Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway. A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set. ROC analysis showed good performance of the prediction model in test set. Then, a nomogram integrating the clinical-pathological factors and riskscore was constructed for predicting 1‐ and 3‐year survival rate.ConclusionOur data provide a comprehensive bioinformatics analysis of AS events in ACC, providing biomarkers for disease progression and a potentially rich source of novel therapeutic targets.https://www.frontiersin.org/articles/10.3389/fendo.2021.538364/fullalternative splicingadrenocortical carcinomaAUCbioinformaticsprognostic model
spellingShingle Weiwei Liang
Fangfang Sun
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
Frontiers in Endocrinology
alternative splicing
adrenocortical carcinoma
AUC
bioinformatics
prognostic model
title Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_full Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_fullStr Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_full_unstemmed Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_short Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_sort prognostic alternative mrna splicing in adrenocortical carcinoma
topic alternative splicing
adrenocortical carcinoma
AUC
bioinformatics
prognostic model
url https://www.frontiersin.org/articles/10.3389/fendo.2021.538364/full
work_keys_str_mv AT weiweiliang prognosticalternativemrnasplicinginadrenocorticalcarcinoma
AT fangfangsun prognosticalternativemrnasplicinginadrenocorticalcarcinoma